Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | ANRO | DSGN | ||
| Company | Urovant Sciences Ltd | Alto Neuroscience Inc | Design Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 16.23 | 16.67 | 9.06 | ||
| High | 16.24 | 18.50 | 9.78 | ||
| Low | 16.21 | 16.30 | 9.06 | ||
| Latest | 16.24 | 17.42 | 9.45 | ||
| Change | +0.01 | +0.25 | +0.17 | ||
| % Change | +0.06% | +1.46% | +1.83% | ||
| Volume | 1,739,000 | 220,200 | 218,800 | ||
| 20-Day Average Volume | 143,510 | 298,235 | 377,170 | ||
| Previous Close | 16.23 | 17.17 | 9.28 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 17.55 | 9.46 | ||
| 20-Day Raw Stochastic | 87.10% | 48.92% | 62.89% | ||
| 20-Day Relative Strength | 65.56 | 57.37 | 53.42 | ||
| Weighted Alpha | +6.45 | +77.76 | +128.11 | ||
| Today's Opinion | 100% Buy | 80% Buy | 80% Buy | ||
| Previous Opinion | 100% Buy | 80% Buy | 80% Buy | ||
| Last Month's Opinion | 96% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | +2.83% since 01/12/26 | +3.62% since 01/12/26 | ||
| Low | 16.20 on 03/24/21 | 15.90 on 01/13/26 | 8.82 on 01/13/26 | ||
| High | 16.25 on 03/25/21 | 18.50 on 01/20/26 | 10.01 on 01/14/26 | ||
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | -12.81% since 12/19/25 | -2.38% since 12/19/25 | ||
| Low | 16.10 on 03/02/21 | 14.08 on 01/06/26 | 8.23 on 01/05/26 | ||
| High | 16.26 on 03/19/21 | 20.84 on 12/23/25 | 10.17 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | +58.36% since 10/20/25 | +62.09% since 10/20/25 | ||
| Low | 16.03 on 12/30/20 | 9.73 on 10/22/25 | 5.28 on 10/22/25 | ||
| High | 16.26 on 03/19/21 | 20.91 on 12/19/25 | 10.31 on 12/05/25 | ||
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | +526.62% since 07/18/25 | +137.44% since 07/18/25 | ||
| Low | 7.15 on 11/02/20 | 2.72 on 07/22/25 | 3.76 on 07/31/25 | ||
| High | 16.26 on 03/19/21 | 20.91 on 12/19/25 | 10.31 on 12/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 533,403 | 528,626 | ||
| Shares Outstanding, K | 32,743 | 31,066 | 56,964 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -146,750,000 | -61,430,000 | -49,590,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -46,800,000 | -14,180,000 | -17,000,000 | ||
| 60-Month Beta | 2.35 | 2.78 | 1.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.52 on 11/12/25 | -0.30 on 11/05/25 | ||
| Latest Earnings Date | 06/17/21 | 03/19/26 | 03/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||